July/August 2010

 

Issue

Supplement

 

EDITOR’S PAGE: Rising to the Challenge of Diabetic Retinopathy

By Allen C. Ho, MD, and Robert L. Avery, MD

NEWS

Retinal Prosthesis Technology

Clinical trials demonstrate that both epiretinal and subretinal approaches provide visual function to blind patients.

By Jennifer Kreatsoulas, PHD, Senior Associate Editor

BUSINESS OF RETINA

Fellows' Focus: Ergonomics for the Retina Specialist

By Allen Chiang, MD; Paul S. Baker, MD; and Eugene A. Milder, MD; With Sunir J. Garg, MD

RETINA SURGERY

GLOBAL PERSPECTIVES: Vital Dyes for Staining Intraocular Membranes and Tissues During Vitrectomy

An overview of vital dyes and their characteristics.

By Mauricio Maia MD, PHD; Michel EID Farah, MD, PHD; Eduardo B. Rodrigues, MD; Andre Maia, MD; Octaviano Magalhaes JR., MD; and Acacio Lima, PHD

RETINA PEARLS: Monitoring for Hydroxychloroquine Retinal Toxicity

Multifocal ERG is useful in detecting early maculopathy.

By Todd Klesert, MD, PHD

SURGICAL UPDATES

A Conservative Approach to 23-gauge Vitrectomy

By Andrew A. Moshfeghi, MD, MBA; and Thomas Albini, MD

ONCOLOGY

CASE REPORTS IN OCULAR ONCOLOGY: Primary Transpupillary Thermotherapy for Choroidal Melanoma

This is still a valuable treatment in properly selected cases.

By Brad E. Kligman, BS; Carol L. Shields, MD; and Jerry A. Shields, MD

COVER STORIES

Update on the Diabetic Retinopathy Clinical Research Network

Recent data and status of some ongoing DRCR.net protocols.

By Sharon D. Solomon, MD; and Neil M. Bressler, MD

Emerging Treatments for Diabetic Macular Edema

A review of agents in clinical trials.

By Avner Ingerman, MD, MSC; and Daniel Dewey-Mattia

Surgical Management of Young Diabetics with Tractional Retinal Detachment

These “hot” eyes can be challenging even for experienced surgeons.

By Tom H. Williamson, MD, MBCHB, FRCS, FRCOPHTH, MD

Cataract Surgery in Diabetic Patients

Excellent outcomes can be achieved in these patients with appropriate attention to details.

By Uday Devgan, MD, FACS, FRCS(GLASG)

MEDICAL RETINA

Point/Counterpoint Early vs Late Pharmacologic Therapy for RVO

By Nancy M. Holekamp, MD and Michael S. Ip, MD

Pharmacogenomics for the Retina Specialist

This specialized discipline may play an important role in improving patient outcomes.

By Stephen G. Schwartz, MD, MBA; and M. Elizabeth Fini, PHD

RETINA SURGERY

Uncoating Coats

Management of advanced disease may include surgery.

By Manish Nagpal, MS, DO, FRCS(UK); and Pravin Jain, FRF, DNB

DEPARTMENTS

INNOVATIONS

5 Questions with Bill Aylward, MD

Dr. Aylward is a Consultant Vitreoretinal Surgeon and former Medical Director at Moorfields Eye Hospital in London. He is also President of the European Society of Retina Specialists (Euretina).

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.